Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment (Q67918972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment (English)

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

10 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

10 December 2022

author name string

L. E. Rönnblom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854511

10 December 2022

G. V. Alm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854511

10 December 2022

K. Oberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854511

10 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1854511

10 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/02841869109092414

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

10 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

537-540

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. A preliminary report

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

10 December 2022

3

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer

10 December 2022

4

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Auto-immune thrombocytopenia related to interferon therapy

10 December 2022

5

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

10 December 2022

6

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Raynaud's phenomenon and cryoglobulinaemia associated with the use of recombinant human alpha-interferon

10 December 2022

7

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Interferon-induced parotitis and epididymitis

10 December 2022

8

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

10 December 2022

9

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

10 December 2022

10

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies

10 December 2022

12

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Leucocyte-derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b

10 December 2022

13

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity

10 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Large-scale Production of Human Leukocyte Interferon Containing 108 Units per ml

10 December 2022

15

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

10 December 2022

16

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a

10 December 2022

17

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin--alone or in combination with 5-FU.

10 December 2022

18

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Effects of interferon-alpha on the expression of a lupus idiotype in normal humans

10 December 2022

19

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Interferon-mediated in vivo induction of beta 2-microglobulin on small-cell lung cancers and mid-gut carcinoids

10 December 2022

21

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-α)

10 December 2022

22

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours

10 December 2022

23

1 reference

https://api.crossref.org/works/10.3109/02841869109092414

10 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854511%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference